共 259 条
[1]
Miller KD(2019)Cancer treatment and survivorship statistics, 2019 CA Cancer J Clin 69 363-385
[2]
Nogueira L(1980)Combined chemotherapy and radiotherapy for locally advanced breast cancer Eur J Cancer 16 351-356
[3]
Mariotto AB(2019)Neoadjuvant Management of Early Breast Cancer: a clinical and investigational position statement Oncologist 24 603-611
[4]
Rowland JH(2012)Pathological complete response and accelerated drug approval in early breast cancer N Engl J Med 366 2438-2441
[5]
Yabroff KR(2017)Neoadjuvant therapy for breast Cancer: established concepts and emerging strategies Drugs 77 1313-1336
[6]
Alfano CM(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 164-172
[7]
Jemal A(2020)The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients Breast Cancer 27 982-988
[8]
Kramer JL(2020)Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients Cancer Biol Ther 21 189-196
[9]
Siegel RL(2016)A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy Cancer 122 2158-2167
[10]
Rubens RDSS(2020)Pretreatment systemic inflammation response index in patients with breast Cancer treated with neoadjuvant chemotherapy as a useful prognostic Indicator Cancer Manag Res 12 1543-1567